Viridian Therapeutics, Inc.\DE ($VRDN)
Filing Information
| Accession Number | 0001104659-26-060294 |
|---|---|
| Form Type | 4 |
| Filing Date | May 13, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
1,176,470
Total Value
$19,999,990.00
P&L
+14.1% (+$2,823,528.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 11, 2026 | Purchase | 1,176,470 | $17.00 | $19,999,990.00 | 5,090,928 | Indirect | By Fairmount Healthcare Fund II L.P. | View Details |